Clinical Assessment

• "Stomach khich / pulling / stretching" - this is the classic urge to move the legs with uncomfortable pulling/crawling sensations = Restless Legs Syndrome (RLS) / Ekbom Syndrome, a very common uremic complication (prevalence ~68% in dialysis patients)
• Restlessness and insomnia - consistent with RLS worsening at night

Diagnosis: Uremic Restless Legs Syndrome (CKD-Associated RLS) with secondary insomnia. The "stomach khich" / stretching / pulling sensation in limbs is the classic description patients use for RLS in the Indian subcontinent.

Treatment Plan with Indian Brand Names

Step 1 - Correct Iron Deficiency First (mandatory before dopaminergics)

Step 2 - Primary Treatment: Dopamine Agonist (First Choice in MHD)

Step 3 - Add Gabapentin (for RLS + painful neuropathy component + better sleep)

Gabapentin is dialyzable - always give AFTER the HD session, not before.

Step 4 - Short-term Sleep Aid (for immediate relief of insomnia)

Step 5 - Address Any Underlying Causes / Aggravating Factors

• Ensure Kt/V ≥1.2 per session. Inadequate dialysis is a major driver of RLS severity.
• If symptoms persist, increase HD frequency/duration.

Step 6 - HCV Consideration (important)

• Avoid amitriptyline and strong sedatives
• If the patient is a candidate for Direct-Acting Antivirals (DAA), consider Sofosbuvir/Velpatasvir (brand: Velpanat - Natco, affordable Indian generic) - however dose adjustment is needed in dialysis patients (Sofosbuvir is cleared by dialysis). Refer to hepatologist.

Non-Pharmacological (Essential)

1. Light walking/leg stretching exercises before bedtime
2. Warm leg soaks/massage before sleep
3. Avoid caffeine, antihistamines, antidepressants that worsen RLS
4. Review all medications for RLS-aggravating drugs (metoclopramide, antipsychotics - avoid if possible)
5. Cold/hot compression on legs at night

Summary Prescription Card

Rx (Patient on MHD, CKD + T2DM + HCV)

1. Iron Sucrose 100 mg IV per dialysis session x 5 [Orofer / Infer]
2. Tab. Ropinirole 0.25 mg PO 2 hrs before bedtime [Ropark / Ropitor]
   - Increase by 0.25 mg every 1-2 weeks. Max 2 mg/day
3. Cap. Gabapentin 100 mg PO immediately AFTER each HD session [Gabapin / Gapitas]
4. Tab. Clonazepam 0.25 mg PO at bedtime x 2-4 weeks [Rivotril / Clonotril]
   OR Tab. Melatonin 3 mg PO at bedtime [Meloset / Melolin]
5. Continue EPO + iron as per nephrology protocol for Hb target 10-11.5 g/dL

Review after 2-4 weeks. If inadequate response, increase ropinirole dose.
If RLS persists despite dopaminergic therapy + gabapentin, consider referral for
increased dialysis sessions or nocturnal HD.

Key Clinical Warnings

Important safety notes:

• Pramipexole (Mirapex/Pramipex) - AVOID in dialysis patients - accumulates and causes severe side effects
• Gabapentin - give ONLY after HD, never before - it is dialyzed out and pre-HD dosing gives no benefit
• Metoclopramide - AVOID - worsens RLS (dopamine antagonist)
• Antihistamines (promethazine/hydroxyzine) - AVOID - worsen RLS significantly
• HCV + DM: Monitor LFTs and blood sugar carefully; HCV itself causes insulin resistance

Clinical Interpretation

• 66 yr, CKD on MHD x 6 months
• Complaint: "stomach khich" (pulling/crawling/creeping sensation in body/abdomen-legs) + "quite pain" (significant pain) + restlessness + insomnia
• Background: T2DM + HCV RNA positive

In Indian patients, RLS is often described as "pet mein khinchaav" or "pair mein khinchaav" (abdominal/leg pulling) - this is the hallmark presentation. The pain component suggests co-existing uremic/diabetic peripheral neuropathy requiring neuropathic pain treatment simultaneously.

COMPLETE PRESCRIPTION

🔵 Step 1 - Correct Iron Deficiency (ROOT CAUSE of RLS)

🔵 Step 2 - Dopamine Agonist (PRIMARY treatment for RLS/Khinchaav)

Ropinirole preferred over Pramipexole in dialysis - pramipexole accumulates in renal failure.

🔵 Step 3 - Gabapentin (for BOTH RLS + Neuropathic pain + Sleep)

Critical rule: Give ONLY after dialysis session - gabapentin is dialyzed out, pre-HD dose is wasted.

🔵 Step 4 - Short-term Sleep Aid (for QUICK relief of insomnia)

🔵 Step 5 - Neuropathic Pain Control (for "quite pain" component)

Use either Gabapentin OR Pregabalin - not both together.

🔵 Step 6 - Anemia Management (worsens RLS)

🔴 DRUGS TO STRICTLY AVOID IN THIS PATIENT

🔵 HCV Consideration

• Refer to Hepatologist/Gastroenterologist for DAA therapy assessment
• Sofosbuvir/Velpatasvir (brand: Velpanat by Natco - affordable Indian generic) is preferred for HCV genotype 1-6 - BUT: sofosbuvir metabolite accumulates in dialysis patients. Use Glecaprevir/Pibrentasvir (brand: Maviret - AbbVie) which is preferred in ESRD/dialysis as it does not require renal dose adjustment
• Avoid hepatotoxic drugs; monitor LFTs monthly

QUICK REFERENCE SUMMARY CARD

Rx - 66yr, CKD on MHD, T2DM, HCV, RLS + Pain + Insomnia

1. Iron Sucrose 100 mg IV per HD session x5 → Orofer / Infer
   (if ferritin <200 or TSAT <20%)

2. Tab. Ropinirole 0.25 mg PO 2 hrs before sleep → Ropark / Ropitor
   Titrate up by 0.25 mg/week. Max 2 mg/day

3. Cap. Gabapin 100 mg PO IMMEDIATELY AFTER each HD session → Gabapin / Gapitas
   On non-HD days: 100 mg at bedtime only

4. Tab. Meloset 3 mg PO 30 min before sleep (daily) → Meloset / Dormix
   [If severe: Tab. Clonotril 0.25 mg at bedtime x 2-3 wks max]

5. EPO 2000-4000 IU SC 3x/week → Epofit / Vintor
   (if Hb <10 g/dL)

Review after 2-4 weeks
Target: Relief of RLS within 1-2 weeks; sleep improvement within days
AVOID: Metoclopramide, Pramipexole, NSAIDs, Tramadol

Non-Drug Measures (Important adjuncts)

1. Leg stretching and calf exercises before bedtime - proven to reduce RLS severity
2. Warm water foot soak for 15 min before sleep
3. Avoid caffeine after 4 PM (tea, coffee)
4. Walking/mild movement when RLS sensation starts
5. Ensure adequate dialysis (Kt/V ≥ 1.2) - underdialysis worsens RLS dramatically
6. Review dialysis adequacy - increasing session duration from 3hrs to 4hrs can significantly reduce uremic RLS

Clinical Note: This prescription is based on standard nephrology guidelines. Always confirm iron studies, Hb, and dialysis adequacy before initiating therapy. The treating nephrologist should review all medications in context of the full clinical picture.